• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类CD38(ADP核糖基环化酶)是免疫球蛋白超家族成员CD31的反受体。

Human CD38 (ADP-ribosyl cyclase) is a counter-receptor of CD31, an Ig superfamily member.

作者信息

Deaglio S, Morra M, Mallone R, Ausiello C M, Prager E, Garbarino G, Dianzani U, Stockinger H, Malavasi F

机构信息

Dipartimento di Genetica, Biologia e Chimica Medica, Università di Torino, Italy.

出版信息

J Immunol. 1998 Jan 1;160(1):395-402.

PMID:9551996
Abstract

Human CD38 is a cell surface molecule involved in the regulation of lymphocyte adhesion to endothelial cells. This suggests that HUVEC bear a ligand(s) for CD38 on the cell surface. By means of the mAb Moon-1, which specifically inhibits CD38-mediated cell adhesion, we have identified a trans-membrane 130-kDa molecule acting as a ligand for CD38. Here, we report that the molecule recognized by the Moon-1 mAb is CD31, a member of the Ig superfamily. This conclusion is based on 1) cross-inhibition assays between Moon-1 and reference anti-CD31 mAbs; 2) sequential immunoprecipitation experiments using Moon-1 and known anti-CD31 mAbs, and 3) reactivity of the Moon-1 mAb with CD31 transfectants. Further, CD31 and CD38 cognate interactions were found to modulate heterotypic adhesion as well as to implement cytoplasmic calcium fluxes identical to those obtained by means of agonistic anti-CD38 mAbs. Other effects tested included the synthesis of messages for a panel of cytokines, markedly increased upon receptor-ligand interactions. These results suggest that the interplay between CD38 and its ligand CD31 is an important step in the regulation of cell life and of the migration of leukocytes (and CD38+ cancer cells) through the endothelial cell wall.

摘要

人类CD38是一种参与调节淋巴细胞与内皮细胞黏附的细胞表面分子。这表明人脐静脉内皮细胞(HUVEC)在细胞表面带有CD38的一种配体。借助特异性抑制CD38介导的细胞黏附的单克隆抗体(mAb)Moon-1,我们鉴定出一种130 kDa的跨膜分子作为CD38的配体。在此,我们报告Moon-1 mAb识别的分子是CD31,它是免疫球蛋白超家族的成员。这一结论基于以下几点:1)Moon-1与参考抗CD31 mAb之间的交叉抑制试验;2)使用Moon-1和已知抗CD31 mAb进行的连续免疫沉淀实验;3)Moon-1 mAb与CD31转染细胞的反应性。此外,发现CD31和CD38的同源相互作用可调节异型黏附,并产生与通过激动性抗CD38 mAb获得的相同的细胞质钙通量。测试的其他效应包括一组细胞因子的信使合成,在受体-配体相互作用时显著增加。这些结果表明,CD38与其配体CD31之间的相互作用是调节细胞生命以及白细胞(和CD38+癌细胞)通过内皮细胞壁迁移的重要步骤。

相似文献

1
Human CD38 (ADP-ribosyl cyclase) is a counter-receptor of CD31, an Ig superfamily member.人类CD38(ADP核糖基环化酶)是免疫球蛋白超家族成员CD31的反受体。
J Immunol. 1998 Jan 1;160(1):395-402.
2
CD38 expression and functional activities are up-regulated by IFN-gamma on human monocytes and monocytic cell lines.在人单核细胞和单核细胞系中,干扰素-γ可上调CD38的表达及功能活性。
J Leukoc Biol. 2001 Apr;69(4):605-12.
3
CD38 binding to human myeloid cells is mediated by mouse and human CD31.CD38与人类髓细胞的结合由小鼠和人类CD31介导。
Biochem J. 1998 Mar 15;330 ( Pt 3)(Pt 3):1129-35. doi: 10.1042/bj3301129.
4
Analysis of the distribution of human CD38 and of its ligand CD31 in normal tissues.正常组织中人类CD38及其配体CD31的分布分析。
J Biol Regul Homeost Agents. 1998 Jul-Sep;12(3):81-91.
5
Role of CD38 and its ligand in the regulation of MHC-nonrestricted cytotoxic T cells.CD38及其配体在MHC非限制性细胞毒性T细胞调节中的作用。
J Immunol. 1998 Feb 1;160(3):1106-15.
6
Human CD38 and its ligand CD31 define a unique lamina propria T lymphocyte signaling pathway.人类CD38及其配体CD31定义了一种独特的固有层T淋巴细胞信号通路。
FASEB J. 2001 Mar;15(3):580-2. doi: 10.1096/fj.00-0522fje. Epub 2001 Jan 19.
7
CD38/CD31, a receptor/ligand system ruling adhesion and signaling in human leukocytes.CD38/CD31,一种调控人类白细胞黏附与信号传导的受体/配体系统。
Chem Immunol. 2000;75:99-120.
8
Human CD38: a (r)evolutionary story of enzymes and receptors.人类CD38:酶与受体的(反)进化故事。
Leuk Res. 2001 Jan;25(1):1-12. doi: 10.1016/s0145-2126(00)00093-x.
9
Human CD38 ligand. A 120-KDA protein predominantly expressed on endothelial cells.人CD38配体。一种主要在内皮细胞上表达的120千道尔顿蛋白质。
J Immunol. 1996 Jan 15;156(2):727-34.
10
Functional associations of CD38 with CD3 on the T-cell membrane.T细胞膜上CD38与CD3的功能关联。
J Biol Regul Homeost Agents. 1997 Oct-Dec;11(4):137-42.

引用本文的文献

1
Unveiling the role of NAD glycohydrolase CD38 in aging and age-related diseases: insights from bibliometric analysis and comprehensive review.揭示烟酰胺腺嘌呤二核苷酸糖水解酶CD38在衰老及与年龄相关疾病中的作用:文献计量分析与综合综述的见解
Front Immunol. 2025 Jun 2;16:1579924. doi: 10.3389/fimmu.2025.1579924. eCollection 2025.
2
Changes of Peripheral T Cells in Systemic Lupus Erythematosus Patients.系统性红斑狼疮患者外周血T细胞的变化
Immun Inflamm Dis. 2025 Feb;13(2):e70156. doi: 10.1002/iid3.70156.
3
Accumulation of CD38 in Hybrid Epithelial/Mesenchymal Cells Promotes Immune Remodeling and Metastasis in Breast Cancer.
CD38在杂交上皮/间充质细胞中的积累促进乳腺癌的免疫重塑和转移。
Cancer Res. 2025 Mar 3;85(5):894-911. doi: 10.1158/0008-5472.CAN-24-0400.
4
Liver X Receptors and Inflammatory-Induced C/EBPβ Selectively Cooperate to Control CD38 Transcription.肝脏X受体与炎症诱导的C/EBPβ选择性协同作用以调控CD38转录。
J Innate Immun. 2025;17(1):56-77. doi: 10.1159/000543274. Epub 2024 Dec 19.
5
Complement System and Adhesion Molecule Skirmishes in Fabry Disease: Insights into Pathogenesis and Disease Mechanisms.补体系统与黏附分子在法布瑞氏病中的交锋:对发病机制和疾病机制的深入了解。
Int J Mol Sci. 2024 Nov 14;25(22):12252. doi: 10.3390/ijms252212252.
6
CD38 ligation in sepsis promotes nicotinamide phosphoribosyltransferase-mediated IL-6 production in kidney stromal cells.脓毒症中CD38连接可促进肾间质细胞中烟酰胺磷酸核糖基转移酶介导的白细胞介素-6生成。
Nephrol Dial Transplant. 2025 Jun 30;40(7):1310-1321. doi: 10.1093/ndt/gfae269.
7
Functional identification of soluble uric acid as an endogenous inhibitor of CD38.鉴定可溶性尿酸作为 CD38 的内源性抑制剂的功能。
Elife. 2024 Nov 11;13:RP96962. doi: 10.7554/eLife.96962.
8
CD38 regulates chronic lymphocytic leukemia proliferation via CD45 phosphatase activity.CD38通过CD45磷酸酶活性调节慢性淋巴细胞白血病的增殖。
Mol Ther Oncol. 2024 Jun 24;32(3):200841. doi: 10.1016/j.omton.2024.200841. eCollection 2024 Sep 19.
9
Biological Functions and Therapeutic Potential of NAD Metabolism in Gynecological Cancers.NAD代谢在妇科癌症中的生物学功能及治疗潜力
Cancers (Basel). 2024 Sep 5;16(17):3085. doi: 10.3390/cancers16173085.
10
Safety and feasibility analysis of rapid daratumumab infusion in Chinese patients with multiple myeloma.中国多发性骨髓瘤患者快速注射达雷妥尤单抗的安全性和可行性分析。
Cancer Med. 2024 Jun;13(11):e7347. doi: 10.1002/cam4.7347.